Introduction {#s1}
============

Maturation of the neurons occurs when the differentiation is mainly completed and the contacts with synaptic targets are mostly established. It includes enlargement of cell soma, strengthening of cytoskeleton, elaboration and refinement of synaptic contacts and other final steps of differentiation. A remarkable event in the maturating neuronal populations is the programmed cell death (PCD) period, where many neurons die apoptotically, thereby determining the final number of neurons (Oppenheim, [@B49]). In the neurons that project out of the brain, such as sensory, autonomic and spinal motoneurons the final number is determined by the extent of trophic support provided by target-derived neurotrophic factors (NTFs) that rescue the neurons from apoptosis (Bibel and Barde, [@B4]; Huang and Reichardt, [@B29]). The PCD lasts during a relatively short time period and when it ends, the neurons are not apoptotic anymore and do not require trophic support for survival. Compared to the processes of the early neurogenesis, including the cell fate determination, migration, and early differentiation of the neurons during embryogenesis, the postnatal maturation of neurons is poorly studied.

Sympathetic neurons of the superior cervical ganglion (SCG) are one of the best studied models for neuronal development. In mouse, the neural crest-derived precursors form the SCG primordia between embryonic day (E) 11.5--14.5 (Nishino et al., [@B48]). Most of SCG neurons become postmitotic before birth of the animals (Hendry, [@B28]; Shi et al., [@B64]). The majority of SCG neurons are noradrenergic and the main neurotransmitter-synthesizing enzymes tyrosine hydroxylase and dopamine β hydroxylase are expressed already in the early sympathetic precursors (Pattyn et al., [@B51]). The neuritogenesis, target innervation and synaptogenesis of the sympathetic neurons begin in embryogenesis and continue after the birth (De Champlain et al., [@B10]; Schotzinger and Landis, [@B60]). During postnatal maturation, the somata of SCG neurons enlarge and synaptic contacts with the targets are refined. The PCD period in SCG neurons occurs during first two postnatal weeks when about 30% of the neurons die (Wright et al., [@B77]). Nerve growth factor (NGF), secreted by the targets of innervation in the limited amounts, rescues the neurons that get it (Harrington and Ginty, [@B25]) whereas neurons that remain without NGF die by unsuppressed apoptosis (Chang et al., [@B7]; Putcha and Johnson, [@B55]; Kristiansen et al., [@B41]; Kristiansen and Ham, [@B39]). The PCD of the SCG neurons ends by about second postnatal week and the neurons are then not dying any more in the absence of NGF (Kole et al., [@B37]). How the NGF-dependency disappears during maturation of SCG neurons is not known but it occurs with the same time schedule both *in vivo* and in the cultured neurons (Easton et al., [@B15]; Francis and Landis, [@B17]; Putcha et al., [@B54]; Glebova and Ginty, [@B19]; Young et al., [@B78]) and remains then a persistent trait, obviously via changes in genome activity. Such stable changes in gene expression could most probably be the basis for many other maturational events as well. However, while the early specification and differentiation of sympathetic neurons are extensively studied (Apostolova and Dechant, [@B2]; Cane and Anderson, [@B6]; Young et al., [@B78]), the postnatal maturation has deserved much less attention (Glebova and Ginty, [@B19]; Kole et al., [@B37]).

Here we set up on search for significantly changed genes during maturation of the SCG neurons. We compared by microarray gene expression profile of the immature (5 DIV---days *in vitro*) and mature (21 DIV) cultures of SCG neurons from newborn mice. Our dataset is deposited to the ArrayExpress database and is a valuable source to select candidate genes in the studies of neuronal maturation. As an example, we studied the changes in the expression of five genes that could be related to neuronal maturation, by quantitative PCR (qPCR) on the whole immature and mature SCG ganglia of mice and rats.

Materials and methods {#s2}
=====================

Neuronal cultures
-----------------

All procedures for animal use were approved by the Estonian Ethics Committee and University of Helsinki Laboratory Animal Centre (Protocol number KEK11-020). SCG neurons from newborn NMRI mice were prepared as described earlier (Yu et al., [@B79]; Hellman et al., [@B26]; Jakobson et al., [@B33], [@B32]). The neurons were plated onto glass coverslips coated with type IV collagen (BD Biosciences, San Diego, CA, USA, \#354233) and grown for 5 DIV (immature) or 21 DIV (mature) in the Neurobasal medium (Invitrogen Ltd, UK) containing B27 serum substitute (Invitrogen) and 30 ng/ml of NGF (PeproTech, Rocky Hill, NJ, USA; \#450-01). The culture medium was changed twice a week. The neurons were harvested in phosphate-buffered saline, pelleted and dissolved in the RNeasy RLT lysis buffer (Qiagen, Venlo, Netherlands, \#79216). Six independent cultures for mature neurons and three independent cultures for immature neurons (ganglia from 12 to 17 pups per culture) were prepared. The majority of the non-neuronal cells were removed by pre-plating step (Yu et al., [@B79]; Hellman et al., [@B26]; Jakobson et al., [@B33], [@B32]) but some always remained and proliferated. The majority of these non-neuronal cells remained attached to the glass coverslips after collection of the cells for RNA extraction. However, to exclude genes of the non-neuronal cells from the analysis with certainty we also collected non-neuronal cells without neurons from the preplating step, that were grown on the non-coated dishes in Neurobasal/B27 medium without NGF for 5 DIV and 21 DIV, one sample for both. No neurons remained alive in these conditions. To verify that the neurons had indeed matured *in vitro* we tested whether the 21 DIV neurons have become independent of NGF for survival, a clear hallmark of the mature SCG neurons. The 5 DIV or 21 DIV cultures were washed three times with NGF-free medium and function-blocking anti-NGF antibodies (Chemicon MAB5260Z) were added. For comparison, the neurons were washed and re-supplemented with NGF. The original number of living neurons was counted under the inverted microscope immediately after NGF deprivation and again 5 days later. The experiment was repeated two times. On all repeats, all 21 DIV neurons remained alive for 5 additional DIV without or with NGF, as reported by others (Easton et al., [@B15]; Putcha et al., [@B54]) whereas the 5 DIV neurons died by NGF deprivation as predicted (Yu et al., [@B79]; Hellman et al., [@B26]; Mätlik et al., [@B45]) (not shown). Typical images are shown on Figure [1](#F1){ref-type="fig"}. The images were captured with inverted microscope (model DM-IRB; Leica, Germany) using HC PL FLUOTAR objective (10 × /0.30), and a 3CCD color video camera (model DXC-950P; Sony) under the control of Image-Pro Plus software version 3.0 (Media Cybernetics, Inc., Rockville, MD, USA).

![**Neuronal cultures used for the microarray study. (A,B)** Images of typical 5 DIV and 21 DIV cultures of the SCG neurons taken before cell collection. The 21 DIV cultures contain many non-neuronal cells but most of them remained attached to the glass surface after collection of the neurons. Scale bar, 100 μM.](fncel-10-00066-g0001){#F1}

Array hybridization
-------------------

RNeasy Kit (Qiagen) was utilized for the purification of total RNA. Cells were disrupted with lysis buffer and homogenized passing the lysate through 20-gauge needle. 70% ethanol was added and the sample was applied to an RNeasy spin column. The RNA bound the membrane of the column and the contaminants were washed away. Purified RNA was eluted in the water. Sample RNAs were analyzed for integrity and quality on Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA). The labeling and hybridization were done using the Ambion WT Expression Kit (Ambion, Austin, TX, USA) and Affymetrix GeneChip WT Terminal Labeling Kit (Affymetrix, Santa Clara, CA, USA), following the manufacturer\'s instructions. The starting amount of total RNA was 50 ng. 15 μg of cRNA was used for single-stranded cDNA-synthesis. A total of 5.5 μg of single-stranded cDNA was fragmented and hybridized onto a Mouse Exon 1.0 ST Array (Affymetrix, Santa Clara, CA, USA) during 17-h incubation at 45°C. Immediately following hybridization, the array was processed using an automated protocol on the GeneChip® Fluidics Station 450, followed by scanning on a GeneChip® Scanner.

Microarray data analysis
------------------------

Signal values were analyzed using Bioconductor (R). Re-mapped gene annotations from the Brainarray Custom chip description files were used (MoEx10stv1_Mm_ENSG, v.17.1.0, <http://brainarray.mbni.med.umich.edu/Brainarray/>), and additional gene information was extracted from EnsEMBL using Biomart-package. Robust Multichip Average (RMA) was used for background correction, quantile normalization and summarization of the signal values. Gene expression values were compared between the immature and mature neurons using the moderated *t*-statistic of limma-package. Benjamini-Hochberg (FDR) procedure was used for multiple testing correction. Genes with FDR adjusted *p* \< 0.05 and fold-change \>2 were considered significantly differentially expressed. List of these significantly up- and down-regulated genes were used for gene ontology enrichment analysis, which was performed with web-based DAVID software (<http://david.abcc.ncifcrf.gov/>) (Huang da et al., [@B30]).

Real-time quantitative PCR analysis
-----------------------------------

RNA from freshly prepared newborn, 14 days old and 21 days old mouse and Sprague Dawley rat SCG, as well as from total brain was purified with GeneElute Mammalian Total RNA Miniprep kit (Sigma, St. Louis, MO, USA). DNase treatment was done separately. RNA clean-up was done with the same RNA purification kit. cDNA synthesis was performed in 20 μl reaction containing 4 μl of 5x RT buffer (Solis Biodyne, Tartu, Estonia), 2.5 μl of 2.5 mM mix of 4 dNTPs (Solis BioDyne), 1 μl of Oligo (dT)~18~ primer (Thermo Fisher Scientific, Rockford, IL, USA), 0.2 μl of Random Hexamer Primer (Thermo Fisher Scientific), 0.5 μl of RiboLock RNase Inhibitor (Thermo Fisher Scientific), 0.5 μl of 200 U/μl MMLV Revertase RNase H minus (Solis BioDyne) and 2 μg of RNA in 11.3 μl water. cDNA was synthesized at 37°C for 90 min and kept thereafter for 5 min at 95°C to inactivate the polymerase. The whole reaction mixture was diluted 2x with RNase-free water to standardize the cDNA amount as 1 μg of RNA in 20 μl of cDNA synthesis reaction. The quality of cDNA synthesis was estimated by PCR for *cyclophilin G* expression.

qPCR analysis was done using Roche Light Cycler 480 II equipment (Roche, Penzberg, Germany). Ten μl reaction mixture contained 5 μl of LightCycler 480 SYBR Green I Master mix (Roche), 10 μM forward and reverse primers (0.5 μl each), 0.8 μl of cDNA (RT mix) and the rest of the volume constituted with RNase-free water. Each reaction was run in triplicates and includes the enzyme activation step 95°C for 4 min continued for 40 times with the following steps: 95°C for 10 s, 56°C for 10 s, 72°C for 10 s. Each run was finished with the melting curve. Neuron-specific Neurofilament H (*Nefh*) was used as the endogenous control gene. *Nefh* appears over threshold at Cp 24--25 in our qPCR conditions in all runs. The laboratory golden standard was the 1:1 mixture of RNAs prepared from the newborn and 21 day whole brains. This mixture, representing all the genes analyzed by qPCR, was used as calibrator in every run. Primer sequences are listed in Supplementary file [S2](#SM2){ref-type="supplementary-material"}. Three or four independent experiments were performed. In each repeat, all genes were analyzed simultaneously on the same PCR run. The means were statistically analyzed with one-way ANOVA followed by Tukey-Kramer Multiple Comparisons Test using GraphPad InStat 3 program (GraphPad Software, Inc., CA, USA).

Results {#s3}
=======

Microarray profiling of gene expression in immature and mature sympathetic neurons
----------------------------------------------------------------------------------

To reveal the genes that are differently expressed in the immature and mature SCG neurons the biotin-labeled single-stranded cDNA samples were hybridized to the Affymetrix GeneChips® Mouse Exon 1.0 ST microarrays. To assess the quality of data, all experimental groups: immature 5 DIV neurons (three repeats) mature 21 DIV neurons (six repeats), 5 DIV non-neuronal cells (one repeat) and 21 DIV non-neuronal cells (one repeat) were subjected to principle component analysis (PCA) and hierarchical clustering. The PCA-plot (Figure [2](#F2){ref-type="fig"}) shows that immature neurons, mature neurons and non-neuronal cells cluster separately from each other but the repeats within these groups cluster together. No obvious outliers were detected. The same conclusions were drawn from hierarchical clustering (not shown).

![**PCA analysis of the samples**. PCA-plots show the location of the samples along the first and second principle component (left) and along the second and third principle components (right). The second principal component separates young (5 DIV) (yg) and mature (21 DIV) (mg) glial cell samples from the neuronal samples, whereas the third principal component separates the young (5 DIV) (y) and mature (21 DIV) (m) neuronal samples.](fncel-10-00066-g0002){#F2}

The significance of differential expression between 5 DIV and 21 DIV neuronal samples, as well as between 5 DIV and 21 DIV non-neuronal samples was assessed using the empirical Bayes moderated *t*-statistics followed by *p*-value adjustment with false discovery rate (FDR) approach. Importantly, the genes that changed significantly in the non-neuronal cells during 3-week culture almost completely differed from those that changed during 3-week maturation of neurons (not shown). We therefore conclude that the small number of non-neuronal cells remaining in the neuronal samples after cell collection could not significantly affect the interpretation of array data.

In the neuronal samples, of about 26,800 genes analyzed, 2461 changed with adjusted *p* \< 0.05, 1310 of these being up-regulated and 1151 down-regulated. Table [1](#T1){ref-type="table"} shows the number of differentially expressed genes with increasingly stringent cut-off parameters. 39 genes were up-regulated and 30 genes down-regulated more than log 1.5-fold with adjusted *p* \< 0.01. These genes are listed in the Tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}, respectively. Data of the whole array are available from the ArrayExpress database (<http://www.ebi.ac.uk/arrayexpress>) under accession number [E-MTAB-3221](E-MTAB-3221).

###### 

**Number of significantly up-or down-regulated genes using different adjusted *p*-values and log fold changes (logFC)**.

                                 **Up**   **Down**
  ------------------------------ -------- ----------
  adj *p* \< 0.05                1310     1151
  adj *p* \< 0.01                587      461
  adj *p* \< 0.05, logFC \>1     169      124
  adj *p* \< 0.01, logFC \>1     121      94
  adj *p* \< 0.05, logFC \>1.5   58       33
  adj *p* \< 0.01, logFC \>1.5   39       30
  adj *p* \< 0.05, logFC \>2     18       11
  adj *p* \< 0.01, logFC \>2     10       10

###### 

**Most significantly up-regulated genes in the 21 DIV compared to 5 DIV SCG neurons (adjusted *p* \< 0.01, log fold change \>1.5)**.

  **Gene ID**                      **Description**                                                    **log FC**   **adj *p*-value**
  -------------------------------- ------------------------------------------------------------------ ------------ -------------------
  [Gjc3](Gjc3)                     Gap junction protein, gamma 3                                      −3.24        0.011109
  [Lynx1](Lynx1)                   Ly6/neurotoxin 1                                                   −3.22        0.000001
  [Cdk18](Cdk18)                   Cyclin-dependent kinase 18                                         −2.79        0.000605
  [Wls](Wls)                       Wntless homolog (Drosophila)                                       −2.39        0.006118
  [Ajap1](Ajap1)                   Adherens junction associated protein 1                             −2.33        0.013279
  [Gda](Gda)                       Guanine deaminase                                                  −2.31        0.000655
  [Tnfrsf10b](Tnfrsf10b)           Tumor necrosis factor receptor superfamily, member 10b             −2.29        0.000126
  [Gria3](Gria3)                   Glutamate receptor, ionotropic, AMPA3 (alpha 3)                    −2.27        0.000590
  [Tnr](Tnr)                       Tenascin R                                                         −2.25        0.001291
  [Vwa5a](Vwa5a)                   Von Willebrand factor A domain containing 5A                       −2.16        0.000297
  [Nt5c1a](Nt5c1a)                 5′-nucleotidase, cytosolic IA                                      −2.13        0.000883
  [Cd44](Cd44)                     CD44 antigen                                                       −2.11        0.007235
  [Cmbl](Cmbl)                     Carboxymethylenebutenolidase-like (Pseudomonas)                    −2.00        0.000186
  [Mfge8](Mfge8)                   Milk fat globule-EGF factor 8 protein                              −1.99        0.003712
  [Ano3](Ano3)                     Anoctamin 3                                                        −1.99        0.001612
  [Mybl1](Mybl1)                   Myeloblastosis oncogene-like 1                                     −1.98        0.000186
  [Herc6](Herc6)                   Hect domain and RLD 6                                              −1.97        0.000264
  [Cast](Cast)                     Calpastatin                                                        −1.97        0.000186
  [Ly96](Ly96)                     Lymphocyte antigen 96                                              −1.97        0.000186
  [Wbscr27](Wbscr27)               Williams Beuren syndrome chromosome region 27 (human)              −1.93        0.001612
  [Ctla2a](Ctla2a)                 Cytotoxic T lymphocyte-associated protein 2 alpha                  −1.90        0.008117
  [Ccnd2](Ccnd2)                   Cyclin D2                                                          −1.90        0.011249
  [1700007K13Rik](1700007K13Rik)   RIKEN cDNA 1700007K13 gene                                         −1.89        0.000034
  [Bmp7](Bmp7)                     Bone morphogenetic protein 7                                       −1.84        0.004110
  [Gal](Gal)                       Galanin                                                            −1.84        0.001046
  [Crebrf](Crebrf)                 CREB3 regulatory factor                                            −1.82        0.003056
  [Susd2](Susd2)                   Sushi domain containing 2                                          −1.82        0.001636
  [Hcn1](Hcn1)                     Hyperpolarization-activated, cyclic nucleotide-gated K+ 1          −1.80        0.002706
  [Ell2](Ell2)                     Elongation factor RNA polymerase II 2                              −1.80        0.001770
  [Stard13](Stard13)               StAR-related lipid transfer (START) domain containing 13           −1.73        0.011192
  [Sh3bgrl2](Sh3bgrl2)             SH3 domain binding glutamic acid-rich protein like 2               −1.73        0.000340
  [Eda2r](Eda2r)                   Ectodysplasin A2 receptor                                          −1.72        0.002128
  [Ptprm](Ptprm)                   Protein tyrosine phosphatase, receptor type, M                     −1.71        0.009108
  [Ephx1](Ephx1)                   Epoxide hydrolase 1, microsomal                                    −1.69        0.000208
  [Slc41a3](Slc41a3)               Solute carrier family 41, member 3                                 −1.66        0.005057
  [Frmpd4](Frmpd4)                 FERM and PDZ domain containing 4                                   −1.65        0.003490
  [Itgb5](Itgb5)                   Integrin beta 5                                                    −1.64        0.000883
  [Sulf2](Sulf2)                   Sulfatase 2                                                        −1.62        0.003117
  [Mr1](Mr1)                       Major histocompatibility complex, class I-related                  −1.59        0.008301
  [Gbp7](Gbp7)                     Guanylate binding protein 7                                        −1.58        0.000330
  [Slc22a18](Slc22a18)             Solute carrier family 22 (organic cation transporter), member 18   −1.57        0.004334
  [Hist1h2bc](Hist1h2bc)           Histone cluster 1, H2bc                                            −1.56        0.003142
  [Rasd2](Rasd2)                   RASD family, member 2                                              −1.54        0.000838

###### 

**Most significantly down-regulated genes in the 21 DIV compared to 5 DIV SCG neurons (adjusted *p* \< 0.01, log fold change \>1.5)**.

  **Gene ID**                      **Description**                                                          **log FC**   **adj *p*-value**
  -------------------------------- ------------------------------------------------------------------------ ------------ -------------------
  [Slc38a4](Slc38a4)               Solute carrier family 38, member 4                                       4.02         0.000186
  [Agtr2](Agtr2)                   Angiotensin II receptor, type 2                                          3.34         0.000126
  [Dchs1](Dchs1)                   Dachsous 1 (Drosophila)                                                  3.12         0.000034
  [Car2](Car2)                     Carbonic anhydrase 2                                                     2.77         0.000007
  [Coch](Coch)                     Coagulation factor C homolog (Limulus polyphemus)                        2.64         0.001140
  [Shisa6](Shisa6)                 Shisa homolog 6 (Xenopus laevis)                                         2.47         0.000264
  [Crtac1](Crtac1)                 Cartilage acidic protein 1                                               2.32         0.001345
  [Stk32b](Stk32b)                 Serine/threonine kinase 32B                                              2.19         0.000932
  [Slc16a12](Slc16a12)             Solute carrier family 16 (monocarboxylic acid transporters), member 12   2.13         0.004841
  [Dcx](Dcx)                       Doublecortin                                                             2.10         0.000497
  [Dpp10](Dpp10)                   Dipeptidylpeptidase 10                                                   2.06         0.014455
  [B3gnt5](B3gnt5)                 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5            1.96         0.000374
  [Zfp57](Zfp57)                   Zinc finger protein 57                                                   1.94         0.000649
  [Vwa5b2](Vwa5b2)                 Von Willebrand factor A domain containing 5B2                            1.84         0.000264
  [Igf2bp3](Igf2bp3)               Insulin-like growth factor 2 mRNA binding protein 3                      1.81         0.000828
  [4833424O15Rik](4833424O15Rik)   RIKEN cDNA 4833424O15 gene                                               1.72         0.000520
  [Gpr119](Gpr119)                 G-protein coupled receptor 119                                           1.72         0.000420
  [BC068157](BC068157)             cDNA sequence BC068157                                                   1.71         0.000186
  [Gjd2](Gjd2)                     Gap junction protein, delta 2                                            1.70         0.013462
  [St8sia2](St8sia2)               ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2             1.69         0.001166
  [Fat3](Fat3)                     FAT tumor suppressor homolog 3 (Drosophila)                              1.68         0.000186
  [Nxph4](Nxph4)                   Neurexophilin 4                                                          1.68         0.000066
  [Rimklb](Rimklb)                 Ribosomal modification protein rimK-like family member B                 1.67         0.001005
  [4931428F04Rik](4931428F04Rik)   RIKEN cDNA 4931428F04 gene                                               1.64         0.014154
  [Cacng4](Cacng4)                 Calcium channel, voltage-dependent, gamma subunit 4                      1.62         0.000186
  [Peg10](Peg10)                   Paternally expressed 10                                                  1.62         0.002032
  [Crip1](Crip1)                   Cysteine-rich protein 1 (intestinal)                                     1.59         0.001874
  [Cxadr](Cxadr)                   Coxsackie virus and adenovirus receptor                                  1.58         0.000208
  [Efnb3](Efnb3)                   Ephrin B3                                                                1.58         0.000186
  [Trim67](Trim67)                 Tripartite motif-containing 67                                           1.57         0.003034
  [Enpp2](Enpp2)                   Ectonucleotide pyrophosphatase/phosphodiesterase 2                       1.57         0.000355
  [Efcab3](Efcab3)                 EF-hand calcium binding domain 3                                         1.54         0.002390
  [Asic1](Asic1)                   Acid-sensing (proton-gated) ion channel 1                                1.50         0.001672

There were no significant changes in the genes for classical markers of sympathetic neurons such as *th* (tyrosine hydroxylase), *ddc* (dopa decarboxylase), *dbh* (dopamine beta hydroxylase), *npy* (neuropeptide Y), *Eno2* (neuron-specific enolase), and *Slc18a2* (vesicular monoamine transporter 2). We conclude that the main sympathetic phenotype is already developed by the first postnatal week.

Gene ontology analysis
----------------------

To reveal the potential functional trends in our data, differentially expressed genes with adjusted *p* \> 0.05 were associated with Gene Ontology (GO) terms using web-based DAVID software (<http://david.abcc.ncifcrf.gov/>) (Huang da et al., [@B30]). Up- and down-regulated genes were analyzed separately. The most abundantly enriched GO-terms among up- and down-regulated genes are presented on Tables [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}, respectively. The full cluster analysis is presented in the Supplementary file [S1](#SM1){ref-type="supplementary-material"}. Of note, many significantly up-regulated GO-terms were related to the neurons, confirming purity of our neuronal samples. As shown in Table [4](#T4){ref-type="table"}, the most potently up-regulated GO-terms during SCG neuronal maturation were associated with neuronal differentiation, including the neurites, synapses, ion channels, neurotransmitters etc.

###### 

**Most significantly enriched GO-terms from the genes up-regulated during maturation of the SCG neurons**.

  **GO-term**                                                                **F.E**.   ***p***   **Genes**
  -------------------------------------------------------------------------- ---------- --------- -------------------------------------------------------------------------------------------------------------------------------------------------------
  Protein retention in ER lumen (GO:0006621, BP)                             11.4       0.02      Kdelr2, Grik5, Kdelr1
  Mitotic chromosome condensation (GO:0007076, BP)                           8.2        0.05      Akap8, Cdca5, Atf6b
  Dendrite morphogenesis (GO:0048813, BP)                                    7.9        0.003     Dscam, Cacna1a, Ctnna2, Dcx, Slc11a2
  Diacylglycerol metabolic process (GO:0046339, BP)                          7.6        0.01      Dgkk, Lipe, Agpat6, Dgkd
  Long-term memory (GO:0007616, BP)                                          7.1        0.06      Chst10, Gria1, Grin1
  Ephrin receptor activity (GO:0005003, MF)                                  6.7        0.005     Ephb2, Epha7, Epha10, Epha6, Epha8
  Dendritic shaft (GO:0043198, CC)                                           6.6        0.005     Cacna1b, Psen1, Asic1, Cacna1c, Slc1a2
  Voltage-gated calcium channel activity (GO:0005245, MF)                    6.2        6.3E-4    Cacna1b, Cacna1a, Cacna1d, Cacng4, Cacna1i, Cacna1c, Ryr1
  UDP-galactosyltransferase activity (GO:0035250, MF)                        6.2        0.002     B4galt2, Ugt8a, B4galt3, B3galnt1, B3galt1, B3gat1
  Retinal ganglion cell axon guidance (GO:0031290, BP)                       5.4        0.03      Bmpr1b, Ephb2, Epha7, Isl1
  Ionotropic glutamate receptor complex (GO:0008328, CC)                     5.3        0.04      Gria1, Grin1, Grik5, Dlg4
  Histone-lysine N-methyltransferase activity (GO:0018024, MF)               5.0        0.002     Kmt2b, Nsd1, Whsc1, Setdb1, Ehmt1, Suv420h2, Setd7
  Regulation of long-term neuronal synaptic plasticity (GO:0048169, BP)      5.0        0.02      Ephb2, Rims1, Grin1, Dlg4, Nras
  Cerebral cortex cell migration (GO:0021795, BP)                            4.8        0.05      Reln, Psen1, Egfr, Lrp8
  Cell adhesion molecule binding (GO:0050839, MF)                            4.7        0.05      Psen1, Neo1, Ctnna2, Mllt4
  Neuropeptide receptor activity (GO:0008188, MF)                            3.9        0.004     Npffr2, Prlhr, Galr1, C130060K24Rik, Npffr1, Ntsr2, Npy1r, Npy5r
  Regulation of axonogenesis (GO:0050770, BP)                                3.9        0.004     Mapt, Ephb2, Lrrc4c, Psen1, Plxna3, Grin1, Plxnb1, Cacna1a
  Cellular response to extracellular stimulus (GO:0031668, BP)               3.8        0.002     Eif2ak4, Tnrc6a, Angptl4, Fos, Psen1, Ppan, Atg16l1, Atf6b, Slc1a2
  PDZ domain binding (GO:0030165, MF)                                        3.7        0.04      Atp2b2, Lpar2, Grik5, Kirrel3, Igsf5
  Protein amino acid glycosylation (GO:0006486, BP)                          3.6        1.8E-5    St8sia2, Pomt2, B3gnt6, Slc4a10, Rpn2, B3galt1, Dolpp1, Fut8, St6galnac3, Trak1, Psen1, B3gnt5, B3galnt1, Rpn1, B3gnt9, St8sia6, St6gal2
  Nuclear chromatin (GO:0000790, CC)                                         3.4        0.003     Phc1, Dnmt3a, Pcgf2, Sirt7, Hira, Akap8, H2afy2, Smarcb1, Zfp57, Tcf3
  Transmembrane receptor protein tyrosine kinase activity (GO:0004714, MF)   3.3        0.003     Pcgf2, Ephb2, Epha7, Epha10, Epha6, Alk, Egfr, Epha8, Kit, Igf1r
  Histone acetylation (GO:0016573, BP)                                       3.3        0.03      Pcgf2, Kat6a, Ing5, Ep300, Mbd3, Tcf3
  Neurotransmitter secretion (GO:0007269, BP)                                3.2        0.04      Cacna1b, Lin7c, Psen1, Cacna1a, Unc13b, Sv2b
  Glycoprotein biosynthetic process (GO:0009101, BP)                         3.1        3.7E-5    St8sia2, Pomt2, B3gnt6, Slc4a10, Rpn2, Large, B3galt1, Dolpp1, Fut8, St6galnac3, Trak1, Psen1, Ext1, B3gnt5, B3galnt1, Rpn1, B3gnt9, St8sia6, St6gal2

Shown are the non-redundant GO-terms with numerical identifiers and the domains Biological Process (BP), Molecular Function (MF) or Cellular Component (CC), the fold enrichment (F.E.), p-value and the included genes.

###### 

**Most significantly enriched GO-terms from the genes down-regulated during maturation of the SCG neurons**.

  **GO-term**                                                                                              **F.E**.   ***p***   **Genes**
  -------------------------------------------------------------------------------------------------------- ---------- --------- -------------------------------------------------
  DNA replication, synthesis of RNA primer (GO:0006269, BP)                                                12.4       0.02      Ccdc111, Helb, Prim1
  Glycolipid catabolic process (GO:0019377, BP)                                                            11.1       0.004     Hexa, Hexb, Galc, Gla
  Arylsulfatase activity (GO:0004065, MF)                                                                  9.8        0.03      Arsb, Arsg, Sulf2
  Phosphatidylinositol metabolic process (GO:0046488, BP)                                                  6.0        0.02      Cd81, Pip4k2c, Pip4k2a, Pip5k1b
  Nucleotide kinase activity (GO:0019201, MF)                                                              5.8        0.009     Ak5, Mpp5, Ak8, Ak1, Cmpk1
  Branched chain family amino acid metabolic process (GO:0009081, BP)                                      5.5        0.01      Auh, Bckdha, Ghr, Aldh6a1, Acad8
  Oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628, MF)   5.4        0.01      Decr1, Pecr, Blvrb, Dpyd, Ptgr1
  Aromatic compound biosynthetic process (GO:0019438, BP)                                                  5.2        0.01      Pts, Mocs1, Spr, Gch1, Pcbd1
  Protein homotetramerization (GO:0051289, BP)                                                             5.1        0.04      H2-D1, Hprt, Gpx3, Pcbd1
  Palmitoyltransferase activity (GO:0016409, MF)                                                           4.8        0.02      Cpt1a, Cpt1c, Cpt2, Zdhhc1, Zdhhc15
  Glycolipid metabolic process (GO:0006664, BP)                                                            4.5        0.009     Hexa, Hexb, Galc, Gla, St6galnac6, Map7
  Dopamine metabolic process (GO:0042417, BP)                                                              4.4        0.02      Sncb, Park2, Hprt, Spr, Nr4a2
  Purine nucleoside metabolic process (GO:0042278, BP)                                                     4.1        0.01      Pcmt1, Hprt, Nudt7, Mat2b, Ocln, Ppcdc
  Acetyl-CoA catabolic process (GO:0046356, BP)                                                            4.1        0.01      Mdh1, Sdha, Nudt7, 2610507B11Rik, Sucla2, Idh3b
  Negative regulation of DNA metabolic process (GO:0051053, BP)                                            4.1        0.03      Ndfip1, Msh6, Brca2, Bcl6, Msh2

Shown are the non-redundant GO-terms with numerical identifiers and the domains Biological Process (BP), Molecular Function (MF) or Cellular Component (CC), the fold enrichment (F.E.), p-value and the included genes.

The GO-terms related to epigenetic repression of the genome and transcription were among the most significantly up-regulated ones, including the genes involved in chromosome condensation (*Akap8, Cdca5*), nuclear chromatin (*Phc1, Dnmt3a, Pcgf2, Sirt7, Hira, H2afy2, Zfp57*), histone acetylation (*Pcgf2, Kat6a*) and histone methyltransferases (*Kmt2b, Nsd1, Whsc1, Setdb1, Ehmt1, Suv420h2*). However, some genes related to transcriptional repression (histone deacetylases *Hdac8, Hdac9, Hdac11*) were down-regulated and some transcriptional activators (*Setd7, Kat6a, Ing5, Ep300*) up-regulated.

Functional categories related to cell surface receptors (several Eph receptors, *Alk, Egfr, Igf1r*) and their signaling (cellular response to extracellular stimulus, transmembrane receptor protein tyrosine kinase activity, PZD domain binding) were also significantly enriched among the up-regulated genes. Also, the cell adhesion-related GO-terms were up-regulated during maturation, including the genes *Psen1* (presenilin 1), *Neo1* (neogenin1), *Ctnna2* (catenin, alpha2), *Mllt4, Reln* (reelin). In contrast, many down-regulated GO-terms appeared to be involved in the various metabolic and biosynthetic processes (Table [5](#T5){ref-type="table"}).

Analysis of the cell death- and survival-related genes
------------------------------------------------------

The ending of PCD is a remarkable event during maturation of the SCG neurons. It is genetically determined (Easton et al., [@B15]; Francis and Landis, [@B17]; Putcha et al., [@B54]; Glebova and Ginty, [@B19]; Young et al., [@B78]) but very little is known about its mechanisms and the involved genes (Kole et al., [@B38]). We therefore paid special attention to the changes in the genes related to cell death and survival. Gene ontology cluster analysis (Supplementary file [S1](#SM1){ref-type="supplementary-material"}) revealed the GO-terms related to apoptosis and cell death among the down-regulated genes (Table [6](#T6){ref-type="table"}) but not among up-regulated genes.

###### 

**GO-terms related to cell death or apoptosis that were significantly down-regulated during maturation of the SCG neurons**.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **GO-term**                                                     **F.E**.   ***p***   **Genes**
  --------------------------------------------------------------- ---------- --------- --------------------------------------------------------------------------------------
  Death (GO:0016265, BP)                                          1.7        3.7E-4    Fkbp8, Cdip1, Slk, Xaf1, 4632434I11Rik, Ggct, Rassf5, Spr, Msh2, Cyfip2, Cib1,\
                                                                                       Gatad2a, Lrdd, Asah2, Bag3, Itgb3bp, Gan, Pura, Naip2, Prune2, Bnip3l, Sqstm1,\
                                                                                       Eda2r, Gulp1, Unc5a, Bcap29, Ypel3, Tax1bp1, Perp, Unc5b, Bcl2l13, Itm2b, Cflar,\
                                                                                       Rad21, Aktip, Hprt, Nr4a2, Rnf144b, Phlda3, Trp53inp1, Ift57, Ebag9, Wwox, Zmat3,\
                                                                                       Mef2a, Faim2, Ppm1f, Triap1, Ppt1, Stk3, Tnfrsf10b, Pea15a

  Programmed cell death (GO:0012501, BP)                          1.7        4.9E-4    

  Cell death (GO:0008219, BP)                                     1.6        6.9E-4    

  Apoptosis (GO:0006915, BP)                                      1.6        0.001     

  Regulation of apoptosis (GO:0042981, BP)                        1.5        0.003     Msh6, S100b, Cdip1, Scg2, Eef1a2, Bcl6, Wrn, Nol3, Ddit3, Foxo1, Cdkn1a, Msh2,\
                                                                                       Sncb, Zak, Mitf, Bag3, Aifm2, Rarb, Glo1, Brca2, Snai2, Bnip3l, Tax1bp1, Perp,\
                                                                                       Gch1, Apoe, Serinc3, Bcl2l13, Itm2b, Adora1, Cflar, Efhc1, Gal, Bmp7, Nr4a2,\
                                                                                       Sycp3, Phlda3, Trp53inp1, Ift57, Jmy, Wwox, Nr3c1, Sgk3, Xrcc4, Triap1, Ppt1, Stk3,\
                                                                                       Gfral, Xrcc5, Tnfrsf10b, Pea15a

  Regulation of programmed cell death (GO:0043067, BP)            1.5        0.003     

  Regulation of cell death (GO:0010941, BP)                       1.5        0.003     

  Positive regulation of programmed cell death (GO:0043068, BP)   1.6        0.03      

  Positive regulation of cell death (GO:0010942, BP)              1.6        0.03      

  Negative regulation of apoptosis (GO:0043066, BP)               1.6        0.03      

  Negative regulation of programmed cell death (GO:0043069, BP)   1.6        0.04      

  Anti-apoptosis (GO:0006916, BP)                                 2.1        0.04      

  Negative regulation of cell death (GO:0060548, BP)              1.6        0.04      

  Positive regulation of apoptosis (GO:0043065, BP)               1.5        0.04      
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Shown are the GO-terms with numerical identifiers, all belonging to the domain Biological Process (BP), the fold enrichment (F.E.) and the p-value. The indicated genes are associated with all respective GO-terms, albeit at different extent.

We analyzed changes in the genes known to be essential in the survival or death of the sympathetic or other neurons. Only few of those were significantly changed. Genes for the neurotrophic factors related to sympathetic neurons *Ngf*, *Bdnf*, *Ntf3* (NT3), *Gdnf*, *Nrtn, Artn* and their respective receptors *Ntrk2* (TrkB), *Ntrk3* (TrkC), *Ret, Ngfr* (p75^NTR^), *Gfra1, Gfra1*, and *Gfra3* were not significantly changed during neuronal maturation. Surprisingly, the gene for NGF receptor *Ntrk1* (TrkA) was missing from the array. However, activated (phosphorylated) TrkA was shown to be more stable in the mature than immature sympathetic neurons (Tsui-Pierchala and Ginty, [@B71]) that could contribute to the insensitivity of mature neurons to NGF for survival. We therefore checked the genes reported to be associated with TrkA, such as *Appl1* and *Gipc1* (Lin et al., [@B43]), Slc9a5 (Diering et al., [@B14]), *Ccm2* (Harel et al., [@B24]), *Stk25* (Costa et al., [@B9]), *Kidins220* (ARMS) (Sniderhan et al., [@B66]), *Ptpn6* (SHP1) (Marsh et al., [@B44]), *Jakmip2* (Necc2) (Díaz-Ruiz et al., [@B13]), *Pincher* (Shao et al., [@B62]), and *Cox* (cytochrome oxidase) genes (Vaughn and Deshmukh, [@B73]). All these genes were not significantly changed, suggesting that regulation of the activity of TrkA could not be the main cause why the mature neurons survive without NGF. However, the levels of *Ptpn11*, encoding for the phosphatase SHP2 and reported to regulate positively the signaling of TrkB receptors (Araki et al., [@B3]; Takai et al., [@B69]), had slightly increased in the mature neurons (Table [4](#T4){ref-type="table"}). The genes reported to interact with p75^NTR^ (Roux and Barker, [@B57]) such as *Sort1* (sortilin), *Traf6, Maged1* (NRAGE), *Zfp110* (NRIF), *Ngfrap1* (NADE), and *Ndn* (Necdin) were also not significantly changed. In conclusion, the independence of the mature SCG neurons from NTFs for survival seems not to be caused by changes in the levels of NTFs, their receptors and known receptor-interacting proteins.

Among the genes for the core apoptotic machinery proteins, including Bcl-2 family members, caspases, Birc (IAP) family members, but also death receptors, their ligands and the proteins of death-inducing signaling complex (DISC) only few changed significantly upon neuronal maturation (Table [7](#T7){ref-type="table"}). The proapoptotic protein Bax is critical for the PCD of SCG neurons (Putcha et al., [@B53]), as in its absence or upon its blockage the neurons do not die by NGF deprivation (Deckwerth et al., [@B11]; Aalto et al., [@B1]). As Bax protein is present but not activated by NGF deprivation in the mature SCG neurons (Easton et al., [@B15]; Putcha et al., [@B54]; Kole et al., [@B38]) we analyzed the reported genes for Bax-interacting proteins, such as *Xrcc6* (Ku70) (Sawada et al., [@B59]), *mt-Rnr2* (humanin) (Guo et al., [@B21]), all *Ywha* (14-3-3) genes (Samuel et al., [@B58]), *Sh3glb1* (Bif-1, endophilin B1) (Wang et al., [@B75]), *Pin1* (Shen et al., [@B63]), *Clu* (clusterin) (Zhang et al., [@B81]), *Npm1* (nucleophosmin) (Kerr et al., [@B35]), *Cfl1* (cofilin) (Simonishvili et al., [@B65]), *Tmbim* genes (Rojas-Rivera and Hetz, [@B56]), and *Nelfb* (Cobra-1) (Ichim et al., [@B31]) and found that these were not significantly changed during neuronal maturation (except slight increase in *Tmbim1*). Only few genes for classical cytoplasmic kinases whose activity could promote cell survival changed significantly during neuronal maturation (Table [7](#T7){ref-type="table"}), whereas, e.g., *Map3k11* (MLK3), *Mapk8* (Jnk1), *Mapk9* (Jnk2), *Akt1*, and *Akt2*, but also phosphatase *Dusp1* (Mkp1) (Kristiansen et al., [@B40]) remained unchanged. Thus, the levels of the members of core apoptotic machinery or classical survival-promoting kinases are not drastically changed during SCG maturation. The mRNA levels of several transcription factors reported to be related to neuronal maturation or apoptosis, such as *Trp73* (p73) (Walsh et al., [@B74]), *Trp53* (p53) (Vaughn and Deshmukh, [@B72]), *Jun* (Easton et al., [@B15]; Ham et al., [@B22]) did not change significantly upon neuronal maturation. However, *Nr1d1* (Chomez et al., [@B8]), *Bcl6* (Otaki et al., [@B50]), *Foxo1* (Gilley et al., [@B18]), and *Klf9* (Lebrun et al., [@B42]) transcripts were all significantly up-regulated in the mature neurons.

###### 

**Genes related to apoptosis or cell survival that changed significantly during SCG neuronal maturation**.

  **Gene ID**              **Description**                                                           **log FC**   **adj *p*-value**   **References**
  ------------------------ ------------------------------------------------------------------------- ------------ ------------------- -----------------------------------------------------
  [Tnfrsf10b](Tnfrsf10b)   Tumor necrosis factor receptor superfamily, member 10b \[TRAIL-R2/DR5\]   −2.29        0.00013             Kichev et al., [@B36]
  [Faim2](Faim2)           Fas apoptotic inhibitory molecule 2                                       −0.84        0.0006              Segura et al., [@B61]; Yu et al., [@B80]
  [Traf4](Traf4)           TNF receptor associated factor 4                                          1.06         0.0014              
  [Traf7](Traf7)           TNF receptor-associated factor 7                                          0.51         0.005               
  [Bak1](Bak1)             BCL2-antagonist/killer 1 \[N-Bak\]                                        0.35         0.032               Sun et al., [@B67]; Jakobson et al., [@B33], [@B32]
  [Bcl2l13](Bcl2l13)       BCL2-like 13 (apoptosis facilitator) \[Bcl-rambo\]                        −0.25        0.042               Kataoka et al., [@B34]
  [Bnip3l](Bnip3l)         BCL2/adenovirus E1B interacting protein 3-like \[Nix\]                    −0.39        0.033               Zhang and Ney, [@B82]
  [Xaf1](Xaf1)             XIAP associated factor 1                                                  −0.71        0.0007              Perrelet et al., [@B52]
  [Aifm2](Aifm2)           Apoptosis-inducing factor, mitochondrion-associated 2                     −0.25        0.049               Hangen et al., [@B23]
  [Akt3](Akt3)             Thymoma viral proto-oncogene 3                                            −0.42        0.0031              
  [Mapk7](Mapk7)           Mitogen-activated protein kinase 7 \[Erk5\]                               0.51         0.0091              
  [Mapk6](Mapk6)           Mitogen-activated protein kinase 6 \[Erk3\]                               0.45         0.014               
  [Mapk3](Mapk3)           Mitogen-activated protein kinase 3 \[Erk1\]                               −0.27        0.036               
  [Ptpn11](Ptpn11)         Protein tyrosine phosphatase, non-receptor type 11 \[SHP2\]               −0.45        0.010               Araki et al., [@B3]
  [Klf9](Klf9)             Krüppel-like factor 9                                                     −1.23        0.0017              Lebrun et al., [@B42]
  [Nr1d1](Nr1d1)           Nuclear receptor subfamily 1, group D, member 1                           −1.04        0.0002              Chomez et al., [@B8]
  [Bcl6](Bcl6)             B cell leukemia/lymphoma 6                                                −1.11        0.0002              Otaki et al., [@B50]
  [Foxo1](Foxo1)           Forkhead box O1                                                           −0.88        0.003               Gilley et al., [@B18]
  [Tmbim1](Tmbim1)         Transmembrane BAX inhibitor motif containing 1                            −0.71        0.002               Rojas-Rivera and Hetz, [@B56]

We were surprised to find that core apoptotic machinery was basically not changed in the neurons whose PCD was over. To confirm this finding we analyzed the array data also with Gene Set Enrichment Analysis (GSEA) another web-based method that uses the whole gene sets to interpret the array data and is therefore useful to test specific hypotheses (Supplementary files [S3](#SM3){ref-type="supplementary-material"}, [S4](#SM4){ref-type="supplementary-material"}). No gene sets related to apoptosis and cell death were revealed in the young neurons, whereas 11 were found in the mature neurons that, however had very high normalized *p*-values and FDR\'s (Supplementary file [S4](#SM4){ref-type="supplementary-material"}) and are most likely false positives. Thus, also GSEA did not reveal significant changes in the classical apoptotic genes in the mature neurons.

qPCR analysis of selected genes in the immature and mature sympathetic ganglia isolated from mouse and rat
----------------------------------------------------------------------------------------------------------

As an example of the usage of array data we selected five genes of interest: *Igf2bp3, Coro1A, Zfp57, Dcx*, and *Apaf* (Table [8](#T8){ref-type="table"}) that could potentially be involved in the neuronal maturation and whose expression changes were also revealed by the microarray. Expression of these genes was analyzed by qPCR in the immature and mature ganglia from two species---mouse and rat. To gain insight whether gene expression changes obtained from *in vitro* cultures reflect the situation *in vivo*, total RNA from freshly prepared whole ganglia from the newborn, 2 and 3 weeks old mice and rats were analyzed. The data were normalized to the *Nefh* (neurofilament heavy polypeptide) gene that is expressed only in the neurons and whose expression level did not change significantly in the SCG during the analyzed time points (see the Materials and Methods).

###### 

**Genes selected from the microarray for qPCR analysis**.

  **Gene ID**          **Description**                                       **log FC**   **adj *p*-value**
  -------------------- ----------------------------------------------------- ------------ -------------------
  [Igf2bp3](Igf2bp3)   Insulin-like growth factor 2 mRNA binding protein 3   1.81         0.000828
  [Zfp57](Zfp57)       Zinc finger protein 57                                1.94         0.052627
  [Dcx](Dcx)           Doublecortin                                          2.10         0.000497
  [Coro1a](Coro1a)     Coronin, actin binding protein 1A                     0.93         0.052746
  [Apaf1](Apaf1)       apoptotic peptidase activating factor 1               0.71         0.095022

The results are presented on Figure [3](#F3){ref-type="fig"}. The mRNAs for *Igf2bp3, Coro1A, Zpf57*, and *Dcx* were drastically reduced by second week of postnatal development in both animal species, and very low levels of these genes persisted by third postnatal week. All these genes were also significantly down-regulated in the microarray assay (Table [8](#T8){ref-type="table"}). *Apaf1* mRNA was also significantly down-regulated in the mature neurons as reported by others (Wright et al., [@B76]), although the change was less significant in the microarray. Thus, the changes in these selected genes determined by microarray in the cultured neurons mostly matched the changes determined by qPCR from the whole ganglia.

![**qPCR analysis of the selected genes during maturation of rat SCG**. Shown are the relative mRNA quantifies (RQ) from newborn (1D), 2 weeks (2W) and 3 weeks (3W) old rat and mouse SCG, normalized to the levels of *Nefh* and calibrated against the laboratory golden standard. Three independent analyses (except four for rat *Apaf1*) were performed and the means were compared with one-way ANOVA followed by Tukey-Kramer Multiple Comparisons Test. Shown are the means ± S.E.M. ^\*^*p* \< 0.05; ^\*\*^*p* \> 0.01, ^\*\*\*^*p* \> 0.001. The null hypothesis was rejected at *p* \< 0.05.](fncel-10-00066-g0003){#F3}

Discussion {#s4}
==========

In this study we compared the gene expression profiles of immature and mature sympathetic neurons to get first insight of the poorly studied processes of maturation, including the control of PCD (Kole et al., [@B37]; Lebrun et al., [@B42]). To our knowledge, the current analysis is the first one performed on the immature and mature SCG neurons. Many changes that occur during neuronal maturation are permanent, suggesting stable changes in the gene expression. Therefore, our analysis, deposited to the public database, could be a valuable source in the studies of neuronal maturation.

The majority of mouse and rat SCG neurons exit the cell cycle before birth (Hendry, [@B28]; Shi et al., [@B64]). Thus, in the neonatal mouse ganglia most of the dividing cells are glial progenitors that give rise to the satellite cells, except a small population of the neurons that became postmitotic during first postnatal week (Shi et al., [@B64]). The neuritogenesis, target innervation and synaptogenesis of the sympathetic neurons also begin in the embryogenesis but occur mostly during postnatal maturation (De Champlain et al., [@B10]; Schotzinger and Landis, [@B60]). This correlates well with our GO analysis showing enrichment of the GO terms related to neurite maturation, synaptic plasticity, neuronal migration, ion channels and neurotransmitter receptors in the mature neurons. Also, the main known markers for the sympathetic neurons (*th, ddc, dbh, npy, Eno2, Slc18a2*) did not change significantly during maturation, showing that the basic sympathetic phenotype was already established in the mice by birth.

Many GO-terms concerning the modification of chromatin and regulation of transcription were significantly up-regulated showing that the postnatal maturation of the sympathetic ganglia involves epigenetic regulation of gene expression that could be the last steps of terminal differentiation. Most of the genes in these GO-terms have been related to chromatin condensation and gene repression, suggesting that in the mature neurons, chromatin is more repressed than in the immature ones. However, some transcriptional repressors were down-regulated and some transcriptional activators up-regulated, suggesting that some genes are also activated during maturation. The GO-terms related to cell surface receptors, their signaling and cell adhesion molecules were also significantly enriched in the mature neurons, suggesting that extracellular signaling and increased cell adhesion play important role in the maturation of SCG neurons. The most significantly down-regulated GO-terms included genes that are related to the metabolic and biosynthetic processes. It is difficult to conclude from the GO-terms the details of the metabolic changes and we therefore conclude only that the metabolic activity is high in the neonatal SCG neurons but could decrease during their maturation.

The end of PCD is a remarkable event in the postnatal maturation of the SCG neurons that occurs largely via intrinsically determined genetic events rather than the extracellular signals, as it appears in the dissociated cultures with similar time schedule as in the whole ganglia *in vivo* (Easton et al., [@B15]; Francis and Landis, [@B17]; Putcha et al., [@B54]; Glebova and Ginty, [@B19]; Young et al., [@B78]). We therefore paid special attention to the genes related to cell survival and death. Individual checking of the classical genes for apoptosis or cell survival did not reveal major changes in their levels during neuronal maturation, except *Apaf1* that was clearly reduced, as also reported by others (Wright et al., [@B76]). This conclusion was supported by alternative GSEA method that also did not reveal significant changes in the apoptotic and cell death related gene sets. Active killing of the neurons via neurotrophin receptor p75^NTR^ (Deppmann et al., [@B12]; Hempstead, [@B27]) or dependence receptors such as Ret (Bordeaux et al., [@B5]) or TrkC (Tauszig-Delamasure et al., [@B70]) but also TrkA (Nikoletopoulou et al., [@B47]) could contribute to neuronal PCD. However, these receptors and the proteins known to associate with them were not significantly down-regulated in the mature SCG neurons and might not be the major mechanism of the NGF-independency. Low levels of *Apaf1* (Wright et al., [@B76]), this study, and repression of transcripts for some Bax-activating BH3-only proteins (Bim, DP5/Hrk, PUMA) by microRNAs in the mature SCG neurons (Kole et al., [@B38]) certainly contribute to their independence of NGF for survival. However, additional yet to be discovered genes/proteins could be involved in the termination of PCD that is a major process crucially changing the status of the neuron (Kole et al., [@B37]). Our cluster analysis revealed significant enrichment of the GO-terms related to cell death and apoptosis among down-regulated genes, but not up-regulated genes, suggesting general suppression of the apoptotic program. Notably the apoptotic functions of most of the genes associated with these GO-terms are currently poorly characterized. We propose that the end of PCD is mediated by yet to be found genes whose products control the activity of apoptotic machinery.

Our microarray data offer a good choice to select the candidate genes for the further studies of neuronal maturation. In this study we selected some genes of interest and studied their expression changes in the immature and mature SCG by qPCR. The selected genes changed significantly during neuronal maturation, were revealed by the gene ontology analysis and could potentially participate in this process, but their role in the cell death and neuronal maturation is currently poorly studied. The genes were analyzed *in vivo* by using neuronal marker gene *Nefh* as a reference to overcome the confounding effect of non-neuronal cells present in the ganglia but mainly removed from the neuronal cultures used for the microarray analysis. The expression changes of the selected genes analyzed from the *in vitro* cultures by microassay and from the whole ganglia by qPCR principally matched. We want to stress, however, that such match is not quaranteed, as the culture conditions may change gene expression. E.g., much smaller down-regulation of the Apaf1 gene was revealed by microarray than by qPCR in our study. How the culture conditions affect gene expression in the SCG neurons is currently poorly known and warrants further studies.

Igf2bp3 (insulin-like growth factor 2 mRNA binding protein 3) is an RNA-binding protein, involved in the RNA synthesis, metabolism and stability in different cells including the neurons (Mori et al., [@B46]). Coro1A, a cytoskeleton binding protein, was shown to bind and regulate TrkA-NGF-containing signaling endosome and thereby increase the survival of the SCG neurons (Suo et al., [@B68]). We analyzed Dcx (doublecortin), a microtubule-associated protein expressed by migrating immature neurons but down-regulated during neuronal maturation (Francis et al., [@B16]; Gleeson et al., [@B20]), and found that it was down-regulated also in the mature SCG. Down-regulation of the mRNA for Apaf1 (apoptotic peptidase activating factor 1) in the mature SCG (Wright et al., [@B76]) was confirmed here as well. Two transcription factors were selected for further analysis. Zfp57 (zinc finger protein 57) is related to genomic methylation imprinting (Zuo et al., [@B83]). Our analysis of genes expressed differently in the immature and mature sympathetic neurons could provide a good candidate gene list for further studies addressing the genetic program governing the maturation of neurons.
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